ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... [Yahoo! Finance]
ADC Therapeutics SA Common Shares (ADCT)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Q4 2025 Net Product Revenue: $22.3 million, up from $16.4 million in Q4 2024. Full-Year 2025 Net Product Revenue: $73.6 million, compared to $69.3 million in 2024. Q4 2025 Total Operating Expenses: $41 million. Full-Year 2025 Total Operating Expenses: $202.9 million. Q4 2025 Non-GAAP Adjusted Operating Expenses: $39.4 million. Full-Year 2025 Non-GAAP Adjusted Operating Expenses: $181.3 million. Q4 2025 Net Loss: $6.4 million or $0.04 per share, compared to $30.7 million or $0.29 per share in Q4 2024. Full-Year 2025 Net Loss: $142.6 million or $1.12 per share, compared to $157.8 million or $1.62 per share in 2024. Cash and Cash Equivalents at Year-End 2025: $261.3 million, up from $250.9 million at the end of 2024. Warning! GuruFocus has detected 6 Warning Signs with ADCT. Is ADCT fairly valued? Test your thesis with our free DCF calculator. Release Date: March 10, 2026 For the complete transcript of the earnings call,
Show less
Read more
Impact Snapshot
Event Time:
ADCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADCT alerts
High impacting ADC Therapeutics SA Common Shares news events
Weekly update
A roundup of the hottest topics
ADCT
News
- ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028 [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update [Yahoo! Finance]Yahoo! Finance
ADCT
Earnings
- 3/10/26 - Beat
ADCT
Sec Filings
- 3/17/26 - Form EFFECT
- 3/16/26 - Form 424B3
- 3/10/26 - Form S-3
- ADCT's page on the SEC website